October 29, 2021
Jaguar Gene Therapy Announces State-of-the-Art Gene Therapy Commercial Manufacturing Facility in North Carolina
Read More
October 28, 2021
Greenstreet to Become CEO of Alnylam at Year-End
Read More
October 22, 2021
Bluebird Withdraws Gene Therapies in Europe as it Winds Down Operations There
Read More
October 18, 2021
NFlection Names William Hodder CEO
Read More
October 4, 2021
Jackson Lab Appoints Lon Cardon as President and CEO
Read More
September 8, 2021
Catabasis Takes New Name to Highlight New Focus
Read More
July 13, 2021
Poxel Shifts Focus to Rare Metabolic Diseases
Read More
June 29, 2021
Orphazyme Lays Off Two-Thirds of Staff After FDA Setback
Read More
June 14, 2021
CDMO Yposkesi Launches Construction of Advanced Therapy Facility Near Paris
Read More
June 3, 2021
Auris Medical Reboots to RNA Therapeutics with Acquisition of Trasir Therapeutics
Read More
April 7, 2021
Ionis Signs Distribution Deal with Sobi and Cuts 70 Percent of Akcea Workforce
Read More
April 1, 2021
Nitto to Invest $226 Million to Expand Oligonucleotide Manufacturing in Massachusetts
Read More
Load More
X